Local Covid-19 vaccine developers say they need support from the Food and Drug Administration (FDA) to provide a special "fast lane" to test their jabs for emergency use. Prof Kiat said the FDA should allow a dual process to conduct human trials for emergency use, together with booster vaccines. Porntip Wiwatwong, chief developer of HXP-GPOVac, an inactivated Covid vaccine from the Government Pharmaceutical Organization (GPO), backed the idea, saying the current process under the FDA's regulations will further delay local vaccine development. Ms Porntip said it would be useful for the local vaccine developers if the FDA could provide assistance to hasten the process. To date, 24.6 million doses have been delivered this year, including eight million this month.
